Filter Results:
(3,572)
Show Results For
- All HBS Web
(3,572)
- People (15)
- News (918)
- Research (2,076)
- Events (7)
- Multimedia (62)
- Faculty Publications (1,464)
Show Results For
- All HBS Web
(3,572)
- People (15)
- News (918)
- Research (2,076)
- Events (7)
- Multimedia (62)
- Faculty Publications (1,464)
- 01 Dec 2023
- News
Thinking Ahead
As we wind down 2023, there’s talk everywhere of generative AI and how it will fundamentally alter the world as we know it; but how does that translate for your corner of the business world? Is TikTok something you need to take seriously? (Is it time to dance?) We... View Details
- 13 Mar 2008
- Working Paper Summaries
An Investigation of Earnings Management through Marketing Actions
- March 1996 (Revised February 1999)
- Case
Vistakon: 1 Day Acuvue Disposable Contact Lenses
By: Alvin J. Silk, Bruce Issacson and Marie Bell
Vistakon, an independent and entrepreneurial subsidiary of Johnson & Johnson, pioneered the production and marketing of disposable contact lenses with the 1987 launch of Acuvue, the first disposable extended-wear lens--a soft contact lens that patients wear for a... View Details
Keywords: Advertising Campaigns; Business Subsidiaries; Business Startups; Corporate Entrepreneurship; Price; Risk Management; Marketing; Product Positioning; Production; Performance Effectiveness; Consumer Products Industry; United States
Silk, Alvin J., Bruce Issacson, and Marie Bell. "Vistakon: 1 Day Acuvue Disposable Contact Lenses." Harvard Business School Case 596-087, March 1996. (Revised February 1999.)
- 12 Sep 2023
- What Do You Think?
Who Gets the Loudest Voice in DEI Decisions?
statement? Nike’s decision to feature in its ads Colin Kaepernick, an American footballer whose patriotism has been questioned, ultimately resulted in what was described by one observer as a “bold success.” On the other hand, brands like... View Details
Keywords: by James Heskett
- December 2022
- Article
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies
By: Pragya Kakani, Michael Chernew and Amitabh Chandra
Context: To what extent does pharmaceutical revenue growth depend on new medicines versus increasing prices for existing medicines? Moreover, does using list prices, as is commonly done, instead of prices net of confidential rebates offered by manufacturers, which are... View Details
Kakani, Pragya, Michael Chernew, and Amitabh Chandra. "The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies." Journal of Health Politics, Policy and Law 47, no. 6 (December 2022): 629–648.
- September 2023
- Supplement
Accelerating with Caution: Forecasting and Managing birddogs’ Growth (B)
By: Mark Egan
As 2017 was drawing to a close, birddogs’ founder and CEO, Peter Baldwin, was working with his CFO Jack Sullivan to prepare for 2018. Their task at hand? To predict the demand for their product in the coming season, determine the appropriate investments in working... View Details
Keywords: Working Capital; Forecasting and Prediction; Expansion; Production; Apparel and Accessories Industry
Egan, Mark. "Accelerating with Caution: Forecasting and Managing birddogs’ Growth (B)." Harvard Business School Supplement 224-024, September 2023.
- October 2019
- Supplement
Impax Laboratories: Executing Accretive Transactions (A)
By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
- October 2019
- Case
Impax Laboratories: Executing Accretive Acquisitions (A)
By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (A)." Harvard Business School Case 220-030, October 2019.
- January 2018
- Case
Scaling Swagbucks (A)
By: Jeffrey F. Rayport and Matthew G. Preble
In early 2014, Chuck Davis (HBS '86) has joined Swagbucks as its first professional CEO to scale a successful and profitable brand promotion and consumer research business. Davis came into the job while serving as a venture partner at TCV, a growth stage VC firm,... View Details
Keywords: Loyalty Management; Scaling; Scale; Entrepreneurship; Human Resources; Employees; Employee Relationship Management; Organizational Change and Adaptation; Organizational Culture; Organizational Design; Leading Change; Growth Management; Religion; Information Technology; Internet and the Web; Transition; Leadership; Web Services Industry; Technology Industry
Rayport, Jeffrey F., and Matthew G. Preble. "Scaling Swagbucks (A)." Harvard Business School Case 818-070, January 2018.
- 25 Jul 2023
- Research & Ideas
Could a Business Model Help Big Pharma Save Lives and Profit?
by harnessing a new business model. The bold approach worked. Gilead, one of the world’s leading antiviral makers, would sell its branded Hepatitis C medicines while offering local manufacturers voluntary licenses to produce generics,... View Details
Gerald Zaltman
*Joined Harvard Faculty: 1991
Prior Faculty Appointments: Northwestern University, 1968-75;
University of Pittsburgh, 1975-91
Prior Faculty Appointments: Northwestern University, 1968-75;
University of Pittsburgh, 1975-91
*Doctoral Degree in Sociology Received from: The John Hopkins University;
MBA Degree Received from: The University of... View Details
- June 2007 (Revised January 2008)
- Case
The Vanguard Group, Inc. in 2006 and Target Retirement Funds
By: Luis M. Viceira
The Vanguard Group is one of the largest asset managers in the U.S., with over $1 trillion in assets, ninety percent of which are mutual fund assets, and more than 12,000 employees at year-end 2006. Vanguard has built a strong reputation as the manager of reference for... View Details
Keywords: Asset Management; Investment Funds; Personal Finance; Brands and Branding; Retirement; Trust; Financial Services Industry; United States
Viceira, Luis M. "The Vanguard Group, Inc. in 2006 and Target Retirement Funds." Harvard Business School Case 207-129, June 2007. (Revised January 2008.)
- 02 Feb 2023
- Research & Ideas
Why We Still Need Twitter: How Social Media Holds Companies Accountable
In May 2021, the Twitter account Brands Getting Owned posted images of signs that workers had taped to the windows of a Chipotle in the United States. One large cardboard sign read, “Sorry for the inconvenience, but due to us being... View Details
- Web
Topics - HBS Working Knowledge
(19) Annual Reports (2) Annuities (1) Arts (2) Asset Management (3) Asset Pricing (4) Assets (11) Attitudes (18) Auctions (4) Balanced Scorecard (11) Banks and Banking (30) Behavioral Finance (7) Behavior (75) Bids and Bidding (1) Bonds (7) Borrowing and Debt (14)... View Details
- Web
HBS - The year in Review
positive labor relations management, was deemed best to support the School’s brand and its educational mission. Its collaboration with Thompson Hospitality, the largest minority-owned food service management company in the country,... View Details
- Web
Mid-US - Global
cofounded Uncle Nearest, a premium American whiskey brand created to honor the legacy of a formerly enslaved man, Nearest Green, who taught Jack Daniel the art of whiskey distillation. Since its launch, Uncle Nearest has become the... View Details
- Web
Human Behavior & Decision-Making - Faculty & Research
future brand availability. We use both field data and experiments to investigate these factors. The findings suggest that canary categories exist (at least in part) because store assortments are not completely adjusted to local... View Details
- October 2013 (Revised January 2016)
- Case
J.C. Penney's 'Fair and Square' Strategy (Abridged)
By: Elie Ofek and Jill Avery
As he gets ready to release 2nd quarter 2012 results, Ron Johnson, the new CEO of department store J.C. Penney, is reconsidering the dramatic changes he initiated for the business model and brand image of his company. A new pricing scheme he put in place in February,... View Details
Keywords: Business Model; Change Management; Marketing Strategy; Price; Consumer Behavior; Decision Making; Management Teams; Brands and Branding; Retail Industry; United States
Ofek, Elie, and Jill Avery. "J.C. Penney's 'Fair and Square' Strategy (Abridged)." Harvard Business School Case 514-063, October 2013. (Revised January 2016.)
- September 2023 (Revised February 2024)
- Case
Accelerating with Caution: Forecasting and Managing birddogs' Growth
By: Mark Egan
As 2017 was drawing to a close, birddogs’ founder and CEO, Peter Baldwin, was working with his CFO Jack Sullivan to prepare for 2018. Their task at hand? To predict the demand for their product in the coming season, determine the appropriate investments in working... View Details
Keywords: Inventory; Working Capital; Forecasting and Prediction; Organizational Change and Adaptation; Financing and Loans; Apparel and Accessories Industry
Egan, Mark. "Accelerating with Caution: Forecasting and Managing birddogs' Growth." Harvard Business School Case 224-023, September 2023. (Revised February 2024.)